Suppr超能文献

水溶性差的药物氟康唑的热敏性眼用泊洛沙姆/吐温/卡波姆原位凝胶:制备及体内外评价

Thermoresponsive ophthalmic poloxamer/tween/carbopol in situ gels of a poorly water-soluble drug fluconazole: preparation and in vitro-in vivo evaluation.

作者信息

Lihong Wang, Xin Che, Yongxue Guo, Yiying Bian, Gang Cheng

机构信息

School of Pharmaceutical Engineering and.

出版信息

Drug Dev Ind Pharm. 2014 Oct;40(10):1402-10. doi: 10.3109/03639045.2013.828221. Epub 2013 Aug 14.

Abstract

The purpose of the present study was to optimize the formulations of the thermoresponsive ophthalmic in situ gels of a poorly water-soluble drug fluconazole (FLU) and evaluate the in vitro and in vivo properties of the formulations. The thermoresponsive ophthalmic FLU in situ gels were prepared by mixing FLU, Poloxamer407, Tween80, benzalkonium chloride and carbopol934 in borate buffer solution. The in vivo eye irritation tests and ophthalmic absorption were carried out in rabbits. The formulation compositions influenced the physicochemical properties of FLU in situ gels. The amount of poloxamer407 in the formulation was the main factor that affected the sol-gel transition temperature of the products. Tween80 not only improved the solubility of the FLU but also affected the products' sol-gel transition temperature. In this study, sol-gel transition temperature was not affected by carbopol934. However, carbopol934 affected pH value, transparency and gelling capacity of the products. The product of the optimized formulation was a pseudoplastic fluid and its sol-gel transition temperature was 30.6 ± 1.2 °C. The autoclaving test showed that the sol-gel transition temperature, the flow ability and the flow behavior of the test samples did not change obviously after autoclaving sterilization at 121 °C and 15 psi for 20 min, thus the autoclaving was an acceptable sterilization method for this preparation. The thermoresponsive ophthalmic FLU in situ gels' in vivo ophthalmic absorption was superior to the conventional FLU eye drop. In conclusion, the thermoresponsive ophthalmic FLU in situ gel is a better alternative than the FLU eye drop.

摘要

本研究的目的是优化难溶性药物氟康唑(FLU)的热敏性眼用原位凝胶制剂,并评估这些制剂的体外和体内性质。通过将氟康唑、泊洛沙姆407、吐温80、苯扎氯铵和卡波姆934在硼酸盐缓冲溶液中混合来制备热敏性眼用氟康唑原位凝胶。在兔子身上进行了体内眼刺激性试验和眼部吸收试验。制剂组成影响了氟康唑原位凝胶的物理化学性质。制剂中泊洛沙姆407的用量是影响产品溶胶-凝胶转变温度的主要因素。吐温80不仅提高了氟康唑的溶解度,还影响了产品的溶胶-凝胶转变温度。在本研究中,卡波姆934不影响溶胶-凝胶转变温度。然而,卡波姆934影响产品的pH值、透明度和胶凝能力。优化制剂的产品为假塑性流体,其溶胶-凝胶转变温度为30.6±1.2℃。高压灭菌试验表明,在121℃、15 psi下高压灭菌20 min后,测试样品的溶胶-凝胶转变温度、流动能力和流动行为没有明显变化,因此高压灭菌是该制剂可接受的灭菌方法。热敏性眼用氟康唑原位凝胶的体内眼部吸收优于传统的氟康唑滴眼液。总之,热敏性眼用氟康唑原位凝胶是比氟康唑滴眼液更好的替代品。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验